Vaccination

France's Sanofi halts work on mRNA Covid vaccine

French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against COVID-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.

Diseases, Conditions, Syndromes

Philippines probing 14 deaths amid dengue vaccine furore

The Philippines is investigating if the deaths of 14 children had any link to a dengue vaccine whose use the government has suspended due to health concerns, officials said Friday.

Diseases, Conditions, Syndromes

Sanofi expands US vaccine venture in COVID-19 race

French pharmaceutical giant Sanofi said Tuesday that it would invest $425 million to expand its vaccine development venture with US start-up Translate Bio as they aim to find a COVID-19 vaccine by next year.

Diabetes

No increased cancer risk with glargine versus human insulin

(HealthDay)—There is no evidence that patients with diabetes who initiate insulin glargine have a higher risk of cancer than similar patients initiating human neutral protamine Hagedorn (NPH) insulin, according to a study ...

Diseases, Conditions, Syndromes

Sanofi halts trial of COVID-19 drug after tests

French pharma giant Sanofi said Tuesday that international Phase 3 clinical tests of its Kevzara drug for serious COVID-19 cases had proved inconclusive and it was halting the trial.

Diseases, Conditions, Syndromes

Philippines suspends world-first dengue vaccine (Update)

The Philippines said Friday it had suspended use of a landmark vaccine for the potentially deadly dengue virus after its manufacturer warned it could worsen the disease in some cases.

page 2 from 13